These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15291236)

  • 21. [Deficit of explicit memory in Parkinson's disease demonstrated by auditory-verbal and visual-design learning tasks].
    Maruyama T
    Nihon Rinsho; 1997 Jan; 55(1):195-201. PubMed ID: 9014449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implicit category learning performance predicts rate of cognitive decline in nondemented patients with Parkinson's disease.
    Filoteo JV; Maddox WT; Salmon DP; Song DD
    Neuropsychology; 2007 Mar; 21(2):183-92. PubMed ID: 17402818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wisconsin Card Sorting Test variables in relation to motor symptoms in Parkinson's disease.
    Alevriadou A; Katsarou Z; Bostantjopoulou S; Kiosseoglou G; Mentenopoulos G
    Percept Mot Skills; 1999 Dec; 89(3 Pt 1):824-30. PubMed ID: 10665014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acute deep brain stimulation of the subthalamic nucleus on auditory event-related potentials in Parkinson's disease.
    Naskar S; Sood SK; Goyal V
    Parkinsonism Relat Disord; 2010 May; 16(4):256-60. PubMed ID: 20116324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy.
    Stanzione P; Semprini R; Pierantozzi M; Santilli AM; Fadda L; Traversa R; Peppe A; Bernardi G
    Electroencephalogr Clin Neurophysiol; 1998 Jan; 108(1):80-91. PubMed ID: 9474065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cognitive function and its evaluation methods in Parkinson's disease--a study including RCPM and ERP].
    Nakazawa M; Kitamura S; Nagazumi A; Terashi A
    Rinsho Shinkeigaku; 1993 Nov; 33(11):1157-63. PubMed ID: 8124874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson's disease.
    Yilmaz FT; Özkaynak SS; Barçin E
    Neurol Sci; 2017 Dec; 38(12):2103-2109. PubMed ID: 28887694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Event related evoked potential responses in epileptic patients.
    Tandon OP; Duhan P
    Indian J Physiol Pharmacol; 2000 Oct; 44(4):461-6. PubMed ID: 11214502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parkinson disease and cognitive evoked potentials].
    Gil R; Neau JP; Toullat G; Rivasseau-Jonveaux T; Lefèvre JP
    Rev Neurol (Paris); 1989; 145(3):201-7. PubMed ID: 2749097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs.
    Prabhakar S; Syal P; Srivastava T
    Neurol India; 2000 Sep; 48(3):239-42. PubMed ID: 11025627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between event-related potentials and frontal-subcortical dysfunction in Parkinson's disease.
    Chen KJ; Lin RT; Liu CK; Tai CT; Lai CL
    Parkinsonism Relat Disord; 2006 Oct; 12(7):453-8. PubMed ID: 16793318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Exposure to traffic noise and effects on attention].
    Tomei G; Tecchio F; Zappasodi F; Ercolani M; Moffa F; Chiovenda P; Ciarrocca M
    Ann Ig; 2006; 18(6):507-19. PubMed ID: 17228608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [P300 and Parkinson disease. The role of cognitive changes].
    Sartucci F; Guerrini V; Tognoni G; Massetani R; Murri L; Muratorio A
    Riv Neurol; 1990; 60(6):229-33. PubMed ID: 2100048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA; Gurvit H; Unsalan P; Horozoglu H; Tuncer N; Feyzioglu A; Gunal DI; Yener GG; Cakmur R; Sahin HA; Emre M
    Mov Disord; 2011 Aug; 26(10):1851-8. PubMed ID: 21500280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in fatigue and sleepiness associated conditions.
    Neu D; Kajosch H; Peigneux P; Verbanck P; Linkowski P; Le Bon O
    Psychiatry Res; 2011 Aug; 189(1):128-34. PubMed ID: 21196050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Auditory evoked potentials in patients with schizophrenia and affective disorders].
    Lebedeva IS; Abramova LI; Bondar' VV; Kaleda VG; Oleĭchik IV; Tsutsul'kovskaia MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(1):56-60. PubMed ID: 11842625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Auditory P300 in the patients with traumatic brain injury].
    Cui Y; Liu F; Zhang XY; Tang P; Liu P; Zhang B; Liu JH
    Fa Yi Xue Za Zhi; 2009 Feb; 25(1):19-23. PubMed ID: 19397208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.